Ceva opens new reference for autogenous vaccine manufacture
Ceva builds on its preventative health strategy with the opening of a new European reference for the manufacture of autogenous vaccines.
Page 5 of articles about vaccine
Hipradermic® 3.0: It’s time to feel the comfort
Hipra has just launched its Hipradermic® 3.0 device, a new and improved version of Hipradermic®: an intradermal needle-free jet injector for the vaccination of pigs.
The Roslin Institute: Stem cell approach to aid vaccine development
Method of producing blood cells will provide platform to aid development of vaccines against deadly infections in pigs such as ASF and PRRS.
Russia discusses developing an ASF vaccine
The Russian Ministry of Agriculture held a meeting on the prospects for developing a vaccine against African swine fever virus in the Russian Federation.
Reproductive performance of influenza A virus infected sows before and after vaccination
Vaccinating against the influenza A (H1N1)pdm09 virus, can improve reproductive performance in sow herds infected with pandemic influenza A virus.
US: APHIS to invest $27 million in foot-and-mouth disease vaccine in case of outbreak
This new program adds to the nation’s level of protection against this devastating disease. In the event of an outbreak, officials would decide if and how to use the available vaccine.
PCV-2d, PCV-2b, PCV-2a. How important are the differences between genotypes for veterinarians?
Serious problems occurred much less frequently with genotype a than with genotype b. Why did the frequency of these genotypes change?
Boehringer Ingelheim’s classical swine fever live vaccine approved
Ingelvac® CSF MLV, the first classical swine fever live vaccine jointly developed by a multinational company and Chinese research institutes.
Pirbright ASF vaccine protects pigs from developing severe disease
100 percent of pigs immunised with the new vaccine survived a lethal dose of ASF virus.
PRRS - Why can't I achieve long-term stability on my farm?
Its high survivability in the environment, a long infective period, limited cross-protection, strains with different pathogenicity, and lateral infections make stabilization difficult.
What can we expect from the new ASF vaccine developed in China?
This vaccine looks promising, but... are we going to see it in Europe?
Pirbright shows new Nipah vaccines create ‘impressive’ immune response
Two new potential vaccines against Nipah virus developed by the University of Parma generate a strong immune response in pigs, and could be the key to preventing this deadly, zoonotic disease.
Highly effective vaccine against ASFV
The gene-deleted HLJ/-18-7GD virus is a safe and effective vaccine against ASFV, and could play an important role in controlling the spread of ASFV.
Increasing Canada's preparedness for ASF with the University of Saskatchewan's VIDO-InterVac
International Vaccine Centre, VIDO-InterVac will commence work in January to develop and test vaccines and antivirals for ASF, seeking to protect the pork industry in Canada and worldwide.
Boehringer Ingelheim introduces DiaTEC purification technology for Ingelvac CircoFLEX®
Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine. With DiaTEC diafiltration technology, Ingelvac CircoFLEX® becomes the first and only non-virucidal PCV2 vaccine for improved capabilities to be freshly mixed on farm.
What you didn't know about live vaccines
In many articles we have explained the difference between killed, live, modified, and subunit vaccines... but this is something totally new.